Fujian Shengdi Pharmaceutical Co., Ltd.

This Phase 2 study tested an injectable drug called HRS9531 in 61 overweight or obese adults to see if it helps with weight loss over 36 weeks. Participants received either the drug or a placebo, and researchers measured changes in body weight. The goal is to find a new treatment…

This completed Phase 2 study tested an experimental pill called HRS9531 in 166 adults with obesity. Participants took either the drug or a placebo daily for 26 weeks. The main goal was to see how much weight they lost compared to those on placebo.

This study tested a new medicine called HRS-7450 in 64 adults who had a stroke within the past 4.5 to 24 hours. The goal was to check if the drug is safe and might help restore blood flow to the brain. Researchers monitored for bleeding and other side effects to see if the treatm…

This early-stage trial tested a single injection of HRS-7249 in 48 healthy adults with high cholesterol. The main goal was to check safety and how the drug moves through the body. Participants were randomly assigned to receive either the drug or a placebo, and researchers monitor…

This early-stage study tested a new injection called HRS-4729 in 102 healthy adults who were overweight or obese. The main goal was to check if the drug is safe and how the body processes it. Participants received either the drug or a placebo, and researchers monitored side effec…

This study tested a new drug called HR20013 to see if it works better than an existing drug (palonosetron) at preventing nausea and vomiting caused by moderate-risk chemotherapy. Over 700 cancer patients who had never had chemo before took part. The main goal was to see how many …

This early study tested a new drug called HRS-9057 in 25 adults with chronic heart failure who still had fluid buildup despite standard diuretics. The drug was given as an injection and compared to tolvaptan pills. The main goal was to check safety and how well the drug removes e…

This study looks at how the body processes HRS9531, an experimental diabetes drug, in people with different levels of kidney function. Researchers gave a single dose to 32 volunteers—some with healthy kidneys and some with mild impairment—and measured drug levels over time. The g…

This early-stage study tested a single injection of HRS-5632 in 50 healthy adults to check its safety and how the body processes it. Participants were aged 18 to 55 and in good health. The study did not aim to treat any disease, only to gather initial safety information.